This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1997.
Company Filing History:
1 out of 834,453 Years Active: 1997
Title: Glenn H Cantor: Innovator in Ribozyme Technology
Introduction
Glenn H Cantor is a notable inventor based in Pullman, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of ribozyme technology aimed at combating viral infections.
Latest Patents
One of his key patents is titled "Ribozyme-mediated inhibition of bovine leukemia virus." This innovative ribozyme is capable of cleaving bovine leukemia virus (BLV) RNA both in a cell-free system and intracellularly. The ribozyme comprises the hammerhead motif flanked by antisense sequences that are complementary to BLV rex/tax RNA. The introduction of this ribozyme into BLV-infected cells results in the inhibition of BLV protein expression, which allows for the control of BLV infection. He holds 1 patent in this area.
Career Highlights
Glenn H Cantor has dedicated his career to advancing the understanding and treatment of viral infections through innovative research and development. His work has implications for both veterinary and human medicine, showcasing the potential of ribozymes in therapeutic applications.
Collaborations
He has collaborated with Guy H Palmer, further enhancing the research and development efforts in the field of virology.
Conclusion
Glenn H Cantor's contributions to ribozyme technology represent a significant advancement in the fight against viral infections. His innovative approach and dedication to research continue to inspire future developments in biotechnology.